✦ LIBER ✦

Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective

✍ Scribed by Madlaina Costa-Scharplatz; Krishnan Ramanathan; Tony Frial; Bruce Beamer; Sanjay Gandhi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CV2 COST-EFFECTIVENESS OF ROSUVASTATIN V

✍ M Costa-Scharplatz; B Beamer; T Frial; SK Gandhi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCV18 COST-EFFECTIVENESS ANALYSIS OF ROS

✍ JS Benner; TW Smith; D Klingman; JC Tierce; CD Mullins; N Pethick; J O'Donnell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Cost Effectiveness of Rosuvastatin in Tr

✍ Paul S.J. Miller; Dean G. Smith; Peter Jones 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 226 KB

PCV89 Cost-Effectiveness Analysis of Ros

✍ M. Brosa; V. Barrios; J.M. Lobos; A. Serrano; M. Capel; C. Alvarez 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Effects of rosuvastatin versus atorvasta

✍ Peter H. Jones; Donald B. Hunninghake; Keith C. Ferdinand; Evan A. Stein; Alex G 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 936 KB

PCV45 COST-EFFECTIVENESS ANALYSIS OF ROS

✍ A Abaci; G Kabakci; A Oguz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB